Sorge L K, Hilf R
Biochim Biophys Acta. 1981 Aug 17;676(2):187-98. doi: 10.1016/0304-4165(81)90186-0.
To investigate the effects of concanavalin A on insulin binding to R3230AC mammary carcinomas, initial experiments were performed to characterize binding of concanavalin A. Concanavalin A binding was found to be specific and saturable. Equilibrium binding experiments demonstrated that addition of low concentrations of concanavalin A enhanced the binding of [3H]concanavalin A, suggestive of positively cooperative interactions. Binding of concanavalin A was responsive to hormonal alterations; tumor cells from diabetic rats showed enhanced binding of concanavalin A and insulin compared to cells from intact rats and administration of insulin to diabetic rats returned concanavalin A and insulin binding to levels seen in controls. Incubation of tumor cells with concanavalin A prior to addition of 125I-labelled insulin resulted in a reduction of insulin-binding capacity; succinyl-concanavalin A did not affect binding of insulin. The present inhibition of insulin binding by concanavalin A was highest at the lower insulin concentrations, providing a linearized Scatchard plot that yielded a calculated Kd value comparable to the low-affinity portion of the curvilinear Scatchard plot for insulin binding. The dissociation rate of bound insulin depended on receptor occupancy. Addition of concanavalin A after insulin binding reached equilibrium resulted in increased insulin binding at higher hormone concentrations, decreased rates of dissociation of insulin and a loss of the correlation between receptor occupancy and dissociation rates. Concanavalin A alone demonstrated an insulin-like effect on glucose transport, which in these tumor cells represents a decrease in transport of 3-O-methylglucose. These results suggest that binding of both concanavalin A and insulin to cells from this hormonally responsive neoplasm is under insulin regulation and demonstrates similar characteristics to those reported for a variety of normal cells. Furthermore, the interaction between concanavalin A and te cell membranes affects the affinity of the insulin receptor for insulin and appears to decrease the observed negative cooperativity.
为了研究伴刀豆球蛋白A对胰岛素与R3230AC乳腺癌细胞结合的影响,首先进行了实验以表征伴刀豆球蛋白A的结合特性。发现伴刀豆球蛋白A的结合具有特异性且可饱和。平衡结合实验表明,添加低浓度的伴刀豆球蛋白A可增强[3H]伴刀豆球蛋白A的结合,提示存在正协同相互作用。伴刀豆球蛋白A的结合对激素变化有反应;与来自正常大鼠的细胞相比,糖尿病大鼠的肿瘤细胞显示出伴刀豆球蛋白A和胰岛素的结合增强,并且给糖尿病大鼠注射胰岛素可使伴刀豆球蛋白A和胰岛素的结合恢复到对照组的水平。在添加125I标记的胰岛素之前,将肿瘤细胞与伴刀豆球蛋白A孵育会导致胰岛素结合能力降低;琥珀酰伴刀豆球蛋白A不影响胰岛素的结合。伴刀豆球蛋白A目前对胰岛素结合的抑制作用在较低胰岛素浓度时最高,提供了一个线性化的Scatchard图,其计算出的Kd值与胰岛素结合的曲线Scatchard图的低亲和力部分相当。结合的胰岛素的解离速率取决于受体占有率。胰岛素结合达到平衡后添加伴刀豆球蛋白A会导致在较高激素浓度下胰岛素结合增加、胰岛素解离速率降低以及受体占有率和解离速率之间的相关性丧失。单独的伴刀豆球蛋白A对葡萄糖转运具有胰岛素样作用,在这些肿瘤细胞中这表现为3-O-甲基葡萄糖转运的减少。这些结果表明,伴刀豆球蛋白A和胰岛素与这种激素反应性肿瘤的细胞的结合受胰岛素调节,并且表现出与多种正常细胞报道的相似特征。此外,伴刀豆球蛋白A与细胞膜之间的相互作用影响胰岛素受体对胰岛素的亲和力,并且似乎降低了观察到的负协同性。